FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3213062408> ?p ?o ?g. }

• W3213062408 endingPage "251" @default.
• W3213062408 startingPage "238" @default.
• W3213062408 abstract "This double-blind (DB), randomized, parallel-group study was designed to evaluate efficacy and safety of paliperidone palmitate 6-month (PP6M) formulation relative to paliperidone palmitate 3-month (PP3M) formulation in patients with schizophrenia.Following screening, patients entered an open-label (OL) maintenance phase and received 1 injection cycle of paliperidone palmitate 1-month (PP1M; 100 or 150 mg eq.) or PP3M (350 or 525 mg eq.). Clinically stable patients were randomized (2:1) to receive PP6M (700 or 1000 mg eq., gluteal injections) or PP3M (350 or 525 mg eq.) in a 12-month DB phase; 2 doses of PP6M (corresponding to doses of PP1M and PP3M) were chosen.Overall, 1036 patients were screened, 838 entered the OL phase, and 702 (mean age: 40.8 years) were randomized (PP6M: 478; PP3M: 224); 618 (88.0%) patients completed the DB phase (PP6M: 416 [87.0%]; PP3M: 202 [90.2%]). Relapse rates were PP6M, 7.5% (n = 36) and PP3M, 4.9% (n = 11). The Kaplan-Meier estimate of the difference (95% CI) between treatment groups (PP6M - PP3M) in the percentages of patients who remained relapse free was -2.9% (-6.8%, 1.1%), thus meeting noninferiority criteria (95% CI lower bound is larger than the pre-specified noninferiority margin of -10%). Secondary efficacy endpoints corroborated the primary analysis. Incidences of treatment-emergent adverse events were similar between PP6M (62.1%) and PP3M (58.5%). No new safety concerns emerged.The efficacy of a twice-yearly dosing regimen of PP6M was noninferior to that of PP3M in preventing relapse in patients with schizophrenia adequately treated with PP1M or PP3M.Clinical Trials.gov identifier: NCT03345342." @default.
• W3213062408 created "2021-11-22" @default.
• W3213062408 creator A5004709278 @default.
• W3213062408 creator A5011875552 @default.
• W3213062408 creator A5018062258 @default.
• W3213062408 creator A5021973179 @default.
• W3213062408 creator A5023586152 @default.
• W3213062408 creator A5032931781 @default.
• W3213062408 creator A5045201341 @default.
• W3213062408 creator A5046162184 @default.
• W3213062408 creator A5047994447 @default.
• W3213062408 creator A5055392951 @default.
• W3213062408 creator A5059294813 @default.
• W3213062408 creator A5064130565 @default.
• W3213062408 creator A5076376973 @default.
• W3213062408 creator A5091766408 @default.
• W3213062408 date "2021-11-13" @default.
• W3213062408 modified "2023-10-10" @default.
• W3213062408 title "A Randomized, Double-Blind, Multicenter, Noninferiority Study Comparing Paliperidone Palmitate 6-Month Versus the 3-Month Long-Acting Injectable in Patients With Schizophrenia" @default.
• W3213062408 cites W1151536748 @default.
• W3213062408 cites W1742833546 @default.
• W3213062408 cites W1763953748 @default.
• W3213062408 cites W1973562905 @default.
• W3213062408 cites W2046784620 @default.
• W3213062408 cites W2047241207 @default.
• W3213062408 cites W2055465804 @default.
• W3213062408 cites W2061331619 @default.
• W3213062408 cites W2096271865 @default.
• W3213062408 cites W2098708127 @default.
• W3213062408 cites W2100554603 @default.
• W3213062408 cites W2104175708 @default.
• W3213062408 cites W2135689380 @default.
• W3213062408 cites W2140606211 @default.
• W3213062408 cites W2154849243 @default.
• W3213062408 cites W2155124212 @default.
• W3213062408 cites W2163878415 @default.
• W3213062408 cites W2171019609 @default.
• W3213062408 cites W2213696776 @default.
• W3213062408 cites W2290987402 @default.
• W3213062408 cites W2527103551 @default.
• W3213062408 cites W2749222622 @default.
• W3213062408 cites W2749602137 @default.
• W3213062408 cites W2756227090 @default.
• W3213062408 cites W2780530330 @default.
• W3213062408 cites W2887988025 @default.
• W3213062408 cites W2893793083 @default.
• W3213062408 cites W2943289961 @default.
• W3213062408 cites W2945429338 @default.
• W3213062408 cites W2954197049 @default.
• W3213062408 cites W2991428633 @default.
• W3213062408 cites W3030944846 @default.
• W3213062408 cites W3036956355 @default.
• W3213062408 cites W3039300106 @default.
• W3213062408 cites W3043299460 @default.
• W3213062408 cites W4244847179 @default.
• W3213062408 doi "https://doi.org/10.1093/ijnp/pyab071" @default.
• W3213062408 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34791283" @default.
• W3213062408 hasPublicationYear "2021" @default.
• W3213062408 type Work @default.
• W3213062408 sameAs 3213062408 @default.
• W3213062408 citedByCount "23" @default.
• W3213062408 countsByYear W32130624082022 @default.
• W3213062408 countsByYear W32130624082023 @default.
• W3213062408 crossrefType "journal-article" @default.
• W3213062408 hasAuthorship W3213062408A5004709278 @default.
• W3213062408 hasAuthorship W3213062408A5011875552 @default.
• W3213062408 hasAuthorship W3213062408A5018062258 @default.
• W3213062408 hasAuthorship W3213062408A5021973179 @default.
• W3213062408 hasAuthorship W3213062408A5023586152 @default.
• W3213062408 hasAuthorship W3213062408A5032931781 @default.
• W3213062408 hasAuthorship W3213062408A5045201341 @default.
• W3213062408 hasAuthorship W3213062408A5046162184 @default.
• W3213062408 hasAuthorship W3213062408A5047994447 @default.
• W3213062408 hasAuthorship W3213062408A5055392951 @default.
• W3213062408 hasAuthorship W3213062408A5059294813 @default.
• W3213062408 hasAuthorship W3213062408A5064130565 @default.
• W3213062408 hasAuthorship W3213062408A5076376973 @default.
• W3213062408 hasAuthorship W3213062408A5091766408 @default.
• W3213062408 hasBestOaLocation W32130624081 @default.
• W3213062408 hasConcept C118552586 @default.
• W3213062408 hasConcept C126322002 @default.
• W3213062408 hasConcept C168563851 @default.
• W3213062408 hasConcept C197934379 @default.
• W3213062408 hasConcept C203092338 @default.
• W3213062408 hasConcept C2776412080 @default.
• W3213062408 hasConcept C2777126507 @default.
• W3213062408 hasConcept C2777288759 @default.
• W3213062408 hasConcept C2780494398 @default.
• W3213062408 hasConcept C2781413609 @default.
• W3213062408 hasConcept C2908997079 @default.
• W3213062408 hasConcept C3020385749 @default.
• W3213062408 hasConcept C42219234 @default.
• W3213062408 hasConcept C71924100 @default.
• W3213062408 hasConcept C98274493 @default.
• W3213062408 hasConceptScore W3213062408C118552586 @default.
• W3213062408 hasConceptScore W3213062408C126322002 @default.
• W3213062408 hasConceptScore W3213062408C168563851 @default.
• W3213062408 hasConceptScore W3213062408C197934379 @default.

• next